Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
61%
Total
Publications
85
Total Open
Publications
52
Total
Citations
3.9K
Open Access
Percentage
61%
Total
Publications
85
Total Open
Publications
52
Total
Citations
3.9K
Breakdown
Publisher Open
23%
Both
27%
Other Platform Open
11%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 26%
11
Hybrid 35%
15
No Guarantees 39%
17
Other Platform Open
Domain 72%
23
Preprint 25%
8
Institution 19%
6
Other Internet 16%
5
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 47 |
PubMed Central | Domain | 23 |
bioRxiv | Preprint | 7 |
Europe PMC | Domain | 5 |
University College London - UCL Discovery | Institution | 2 |
desy.de OAI-PMH Repository | Institution | 2 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
Indiana University - Purdue University Indianapolis - IUPUI ScholarWorks | Institution | 1 |
Indiana University - IUScholarWorks | Institution | 1 |